期刊文献+

生长激素在门脉高压症大出血断流术后的应用体会 被引量:1

Application of growth hormone after disconnection of portalsystemic shunt for the portal hypertension patients with bleeding
下载PDF
导出
摘要 目的 :探讨生长激素 (GH)对肝功能ChildC级门脉高压症合并上消化道大出血内科治疗无效而被迫行断流术后出现的顽固性低蛋白血症和难控性腹水的治疗价值。 方法 :2 0例病人随机分为三组 :A组为 ,肠外营养(PN) 8天 ;B组为PN +GH ,PN同A组 ,应用重组人GH(rhGH) 8U ,1次 /d ,7天 ;C组为单纯rhGH组 ,rhGH应用方法同B组。术后动态观察血浆蛋白、腹水、病死率和其他一般情况。 结果 :PN +rhGH术后 1周起白浆蛋白水平高于其他两组 ,腹水消退快 ,一般情况好 ,无死亡病例。 结论 :肝功能ChildC级门脉高压合并上消化道大出血内科治疗无效 ,急诊断流术后应用PN加生长激素对纠正顽固性低蛋白血症、控制术后腹水的增长有良好的疗效 ,作用较持久 ,可减少术后病死率 ,改善病人生活质量 ,但一定要给予静脉营养支持以提供必要的蛋白合成底物和能量。同时临床经验告诉我们 ,rhGH的应用一定要足量、足疗程。 Objectives:To study the effects of recombinant human growth hormone(rhGH) in treatment of portal hypertension patients with hypoproteinemia and intractable ascites. Methods:20 cases of patients with portal hypertention (Child's Class C) with bleeding were randomly divided into 3 groups and rhGH was used to treat hypoproteinemia and intractable ascites only or with parenteral nutrition in the postoperative period. Results:The hypoproteinia and ascites were alleviated,the incidence rate of postoperative complications and mortality were reduced,and the life quality of the patients was improved in patients in whom rhGH had been used,especially when used simultaneously with parenteral nutrition. Conclusions:The postoperative use of rhGH is beneficial to alleviate the hypoproteinemia and ascites in patients with portal hypertention,especially when combined with the use of parenteral nutrition.
出处 《肠外与肠内营养》 CAS 2001年第2期73-75,共3页 Parenteral & Enteral Nutrition
关键词 生长激素 门脉高压症 低白蛋白血症 腹水 应用 Growth hormone Portal hypertension Hypoproteinemia Ascites
  • 相关文献

参考文献1

  • 1吴阶平,黄家驷外科学,1994年,13491361页

同被引文献12

  • 1顾军,黎介寿,李维勤,黄进,尹路,刘放南.重组生长激素对严重感染后蛋白质代谢影响的实验研究[J].中华外科杂志,1997,35(2):104-107. 被引量:127
  • 2Cameron JL, Pitt HA ,Yeo CJ, et al. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality [J]. Ann Surg, 1993, 217(5) :430.
  • 3Christensen T, Kehlet H. Postoperative fatigue [J]. World J团组织Surg, 1993, 17(2) : 220.
  • 4Carli F, Webster JD, Halliday D. Growth hormone modulates amino acid oxidation in the surgical patient : leucine kinetics during the fasted and fed state using moderate nitrogenous and caloric diet and recombinant human growth hormone [J]. Metabolism, 1997,46(1) : 23.
  • 5Carli F, Webster JD, Halliday D. A nitrogen-free hypocaloric diet and recombinant human growth hormone stimulate postoperative protein synthesis: fasted and fed leuicne kinetics in the surgical patient [J]. Metabolism, 1997, 46(7) : 796.
  • 6Vara-Thorbeck R, Guerrero JA, Rosell J, etal. Exogenous growth hormone: effects on the catabolic response to surgically produced acute stress and on postoperative immune function [J].World J Surg, 1993, 17(4) : 530.
  • 7Vara-Thorbeck R, Guerrero JA, Ruiz-requena E, et al. Can the use of growth hormone reduced the postoperative fatigue syndrome? [J]. World J Surg, 1996, 20(1):81.
  • 8Tacke J, Bolder U, Herrmann A, et al. Long-term risk of gastrointestinal tumor recurrence after postoperative treatment with recombinant human growth hormone [J]. JPEN J Parenter Enteral Nutr, 2000, 24(3) : 140.
  • 9吴阶平 裘法祖主编.黄家驷外科学:第6版[M].北京:人民卫生出版社,1999.1250.
  • 10李立,冉江华,陆晓青,孙锋,唐继红.检测阻塞性黄疸患者手术前后细胞因子的临床意义[J].中国普外基础与临床杂志,2000,7(3):170-171. 被引量:4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部